186 related articles for article (PubMed ID: 23580407)
1. Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma.
Lu CY; Lin KY; Tien MT; Wu CT; Uen YH; Tseng TL
Genes Chromosomes Cancer; 2013 Jul; 52(7):636-43. PubMed ID: 23580407
[TBL] [Abstract][Full Text] [Related]
2. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
Xie K; Liu J; Chen J; Dong J; Ma H; Liu Y; Hu Z
Gene; 2014 Jun; 543(1):101-7. PubMed ID: 24704024
[TBL] [Abstract][Full Text] [Related]
3. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
4. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
5.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
6. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
7. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
8. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
Long XR; He Y; Huang C; Li J
Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y
Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
Huang J; Wang Y; Guo Y; Sun S
Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
[TBL] [Abstract][Full Text] [Related]
14. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma.
Wu G; Wang Y; Lu X; He H; Liu H; Meng X; Xia S; Zheng K; Liu B
BMC Cancer; 2015 Mar; 15():182. PubMed ID: 25880458
[TBL] [Abstract][Full Text] [Related]
15. [Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance].
Zhan MX; Li Y; Hu BS; Shao PJ; Meng QW; He X; Huang JW; Lu LG
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1830-2. PubMed ID: 24124720
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
20. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.
He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS
Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
